A team of Korean researchers has, for the first time in the world, developed a technology capable of enabling early diagnosis of major neurological disorders, including epilepsy, Parkinson's disease, and schizophrenia, using only a small amount of saliva.
This study was conducted jointly by a research team led by Dr. Sung-Gyu Park of the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science (KIMS), together with Prof. Ho Sang Jung's team at...
Researchers have uncovered a promising new treatment target for a severe autoimmune brain disorder. The finding could help drive the development of more...
Summary: Schizophrenia treatment has been dominated by dopamine-targeting drugs for decades, but these often fail to address the debilitating cognitive and negative symptoms...
Summary: Schizophrenia and psychosis do not follow a single, predictable path. A landmark 10-year study has mapped the complex interaction between brain maturation,...